Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice
Open accessAbstract
UNLABELLED: Activation of farnesoid X receptor (Fxr, Nr1h4) is a major mechanism in suppressing bile-acid synthesis by reducing the expression levels of genes encoding key bile-acid synthetic enzymes (e.g., cytochrome P450 [CYP]7A1/Cyp7a1 and CYP8B1/Cyp8b1). FXR-mediated induction of hepatic small heterodimer partner (SHP/Shp, Nr0b2) and intestinal fibroblast growth factor 15 (Fgf15; FGF19 in humans) has been shown to be responsible for this suppression. However, the exact contribution of Shp/Fgf15 to this suppression, and the associated cell-signaling pathway, is unclear. By using novel genetically modified mice, the current study showed that the intestinal Fxr/Fgf15 pathway was critical for suppressing both Cyp7a1 and Cyp8b1 gene expression, but the liver Fxr/Shp pathway was important for suppressing Cyp8b1 gene expression and had a minor role in suppressing Cyp7a1 gene expression. Furthermore, in vivo administration of Fgf15 protein to mice led to a strong activation of extracellular signal-related kinase (ERK) and, to a smaller degree, Jun N-terminal kinase (JNK) in the liver. In addition, deficiency of either the ERK or JNK pathway in mouse livers reduced the basal, but not the Fgf15-mediated, suppression of Cyp7a1 and Cyp8b1 gene expression. However, deficiency of both ERK and JNK pathways prevented Fgf15-mediated suppression of Cyp7a1 and Cyp8b1 gene expression. CONCLUSION: The current study clearly elucidates the underlying molecular mechanism of hepatic versus intestinal Fxr in regulating the expression of genes critical for bile-acid synthesis and hydrophobicity in the liver.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Intestinal Fgf15 is a potent inhibitor of Cyp7a1 expression and BA synthesis.
“Intestinal Fgf15 is a potent inhibitor of Cyp7a1 expression and BA synthesis (Kong et al., 2012).”
From Microbiota-related Changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism (2017) · cites this paper as Kong et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714 · see citing works
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274 · see citing works
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940 · see citing works
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865 · see citing works
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819 · see citing works
Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636 · see citing works
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · see citing works
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487 · see citing works
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176 · see citing works
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-p, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 751 · see citing works
Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K., Donahee, M. H., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 698 · see citing works
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S., & Gonzalez, F. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 575 · see citing works
Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
Chiang, J. Y. L. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.006 · Cited by 550 · see citing works
Redundant Pathways for Negative Feedback Regulation of Bile Acid Production
Wang, L., Lee, Y., Bundman, D. S., Han, Y., Thevananther, S., Kim, C.-S., Chua, S. S., Wei, P. Y., Heyman, R. A., Karin, M., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00187-9 · Cited by 475 · see citing works
Song, K., Li, T., Owsley, E., Strom, S. C., & Chiang, J. Y. L. (2008) · Hepatology · doi:10.1002/hep.22627 · Cited by 414 · see citing works
Yu, C., Wang, F., Kan, M., Jin, C., Jones, R. B., Weinstein, M., Deng, C.-X., & Mckeehan, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15482 · Cited by 357 · see citing works
Kemper, J. K., Xiao, Z., Ponugoti, B., Miao, J., Fang, S., Kanamaluru, D., Tsang, S., Wu, S.-Y., Chiang, C.-M., & Veenstra, T. D. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.009 · Cited by 332 · see citing works
Modica, S., Petruzzelli, M., Bellafante, E., Murzilli, S., Salvatore, L., Celli, N., Di Tullio, G., Palasciano, G., Moustafa, T., Halilbasic, E., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.028 · Cited by 275 · see citing works
Impaired negative feedback suppression of bile acid synthesis in mice lacking βKlotho
Ito, S., Fujimori, T., Furuya, A., Satoh, J., Nabeshima, Y., & Nabeshima, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23076 · Cited by 248 · see citing works
Hodge, C. L., Liao, J., Stofega, M. R., Guan, K., Carter‐Su, C., & Schwartz, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31327 · Cited by 248 · see citing works
Rao, A., Haywood, J., Craddock, A. L., Belinsky, M. G., Kruh, G. D., & Dawson, P. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712328105 · Cited by 226 · see citing works
Lee, Y.-K., Schmidt, D. R., Cummins, C. L., Choi, M., Peng, L., Zhang, Y., Goodwin, B. J., Hammer, R. E., Mangelsdorf, D. J., & Kliewer, S. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0565 · Cited by 151 · see citing works
Wright, T. J., Ladher, R., Mcwhirter, J., Murre, C., Schoenwolf, G., & Mansour, S. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.02.003 · Cited by 144 · see citing works
Mataki, C., Magnier, B. C., Houten, S. M., Annicotte, J., Argmann, C., Thomas, C., Overmars, H., Kulik, W., METZGER, D., Auwerx, J. H., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00852-07 · Cited by 141 · see citing works
Effects of FXR in foam-cell formation and atherosclerosis development
Guo, G. L., Santamarina-Fojo, S., Akiyama, T. E., Amar, M. J., Paigen, B. J., Brewer, B., & Gonzalez, F. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.09.018 · Cited by 130 · see citing works
Zhang, Y.-X., Xu, P., Park, K., Choi, Y., Moore, D. D., & Wang, L. (2008) · Hepatology · doi:10.1002/hep.22342 · Cited by 118 · see citing works
Molecular Basis of Endocrine Regulation by Orphan Nuclear Receptor Small Heterodimer Partner
Chanda, D., Park, J., & Choi, H.-S. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-103 · Cited by 108 · see citing works
Yu, C., Wang, F., Jin, C., Huang, X., & McKeehan, W. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411771200 · Cited by 103 · see citing works
Tissue-specific function of farnesoid X receptor in liver and intestine
Zhu, Y., Li, F., & Guo, G. L. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2010.12.018 · Cited by 101 · see citing works
Pandak, W. M., Heuman, D. M., Hylemon, P. B., Chiang, J. Y. L., & Vlahčevič, Z. R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90083-7 · Cited by 71 · see citing works
Activation of Bile Acid Biosynthesis by the p38 Mitogen-activated Protein Kinase (MAPK)
Xu, Z., Tavares-Sanchez, O. L., Li, Q., Fernando, J. F. A., Rodriguez, C. M., Studer, E. J., Pandak, W. M., Hylemon, P. B., & Gil, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611481200 · Cited by 46 · see citing works
Martínez-Fernández, P., Hierro, L., Jara, P., & Álvarez, L. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90371.2008 · Cited by 27 · see citing works
Kong, B., & Guo, G. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020307 · Cited by 22 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlstrom, A. M., Sayin, S. I., Marschall, H., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,903 · see citing works
Pleiotropic Roles of Bile Acids in Metabolism
de Aguiar Vallim, T. Q., Tarling, E. J., & Edwards, P. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.013 · Cited by 1,209 · see citing works
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Sun, L., Xie, C., Wang, G., Wu, Y., Wu, Q., Wang, X., Liu, J., Deng, Y., Xia, J., Chen, B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0222-4 · Cited by 1,011 · see citing works
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935 · see citing works
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76738 · Cited by 693 · see citing works
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
Chiang, J. Y. L., & Ferrell, J. M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00223.2019 · Cited by 580 · see citing works
Molecular physiology of bile acid signaling in health, disease, and aging
Perino, A., Demagny, H., Velazquez-Villegas, L., & Schoonjans, K. (2021) · Physiological Reviews · doi:10.1152/physrev.00049.2019 · Cited by 481 · see citing works
Bile acid nuclear receptor FXR and digestive system diseases
Ding, L., Yang, L., Wang, Z., & Huang, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.01.004 · Cited by 477 · see citing works
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
Sun, L., Cai, J., & Gonzalez, F. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00404-2 · Cited by 443 · see citing works
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
Degirolamo, C., Sabbà, C., & Moschetta, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.9 · Cited by 424 · see citing works
FXR signaling in the enterohepatic system
Matsubara, T., Li, F., & Gonzalez, F. J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.05.004 · Cited by 383 · see citing works
Autophagy in liver diseases: A review
Qian, H., Chao, X., Williams, J. A. R., Fulte, S., Li, T., Yang, L., & Ding, W. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100973 · Cited by 377 · see citing works
Liu, Y., Chen, K., Li, F., Gu, Z., Liu, Q., He, L., Shao, T., Song, Q., Zhu, F., Zhang, L., et al. (2019) · Hepatology · doi:10.1002/hep.30975 · Cited by 373 · see citing works
Golubeva, A. V., Joyce, S. A., Moloney, G., Burokas, A., Sherwin, E., Arboleya, S., Flynn, I., Khochanskiy, D., Moya-Pérez, A., Peterson, V., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.09.020 · Cited by 364 · see citing works
The role of bile acids in carcinogenesis
Režen, T., Rozman, D., Kovàcs, T., Kovács, P., Sipos, A., Bai, P., & Mikó, E. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04278-2 · Cited by 299 · see citing works
Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis
Chiang, J. Y. L., & Ferrell, J. M. (2020) · Liver Research · doi:10.1016/j.livres.2020.05.001 · Cited by 303 · see citing works
Discovery of farnesoid X receptor and its role in bile acid metabolism
Chiang, J. Y. L., & Ferrell, J. M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111618 · Cited by 298 · see citing works
Bile acids are nutrient signaling hormones
Zhou, H., & Hylemon, P. B. (2014) · Steroids · doi:10.1016/j.steroids.2014.04.016 · Cited by 285 · see citing works
Bile acids as metabolic regulators
Li, T., & Chiang, J. Y. L. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000156 · Cited by 270 · see citing works
Bile acids and their receptors in metabolic disorders
Fiorucci, S., Distrutti, E., Carino, A., Zampella, A., & Biagioli, M. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101094 · Cited by 262 · see citing works
Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases
Li, Y., Tang, R., Leung, P. S. C., Gershwin, M. E., & Ma, X. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.002 · Cited by 247 · see citing works
Copple, B. L., & Li, T. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.007 · Cited by 235 · see citing works
Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites
Chen, W., & Pang, Y. (2021) · Metabolites · doi:10.3390/metabo11120869 · Cited by 228 · see citing works
Intestinal absorption of bile acids in health and disease
Ticho, A. L., Malhotra, P., Dudeja, P. K., Gill, R. K., & Alrefai, W. A. (2019) · Comprehensive physiology · doi:10.1002/cphy.c190007 · Cited by 215 · see citing works
Chen, L., Jiao, T., Liu, W., Luo, Y., Wang, J., Guo, X., Tong, X., Lin, Z., Sun, C., Wang, K., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.08.008 · Cited by 219 · see citing works
Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.
Angelin, B., Larsson, T., & Rudling, M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.001 · Cited by 210 · see citing works
Qi, Y., Jiang, C., Cheng, J., Krausz, K. W., Li, T., Ferrell, J. M., Gonzalez, F. J., & Chiang, J. Y. L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.04.008 · Cited by 205 · see citing works
Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids
Klaassen, C. D., & Cui, J. Y. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.065698 · Cited by 208 · see citing works
Xu, H., Fang, F., Wu, K., Song, J., Li, Y., Lu, X., Liu, J., Zhou, L., Yu, W., Yu, F., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01709-5 · Cited by 206 · see citing works
Bile Acids and FXR: Novel Targets for Liver Diseases
Stofan, M., & Guo, G. L. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00544 · Cited by 202 · see citing works
Sun, R., Yang, N., Kong, B., Cao, B., Feng, D., Yu, X., Ge, C., Huang, J., Shen, J., Wang, P., et al. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.106617 · Cited by 199 · see citing works
Self-citationBile acid signaling in the regulation of whole body metabolic and immunological homeostasis
Jia, W. P., Li, Y., Cheung, K. C.-P., & Zheng, X. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2353-0 · Cited by 201 · see citing works
Molecular basis of bile acid-FXR-FGF15/19 signaling axis
Katafuchi, T., & Makishima, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116046 · Cited by 193 · see citing works
Lake, A. D., Novák, P., Shipkova, P. A., Aranı́bar, N., Robertson, D. G., Reily, M. D., Lu, Z. J., Lehman‐McKeeman, L. D., & Cherrington, N. J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.022 · Cited by 189 · see citing works
Zhang, L., Yang, Z., Trottier, J., Barbier, O., & Wang, L. (2016) · Hepatology · doi:10.1002/hep.28882 · Cited by 185 · see citing works
Physiology and Physical Chemistry of Bile Acids
di Gregorio, M. C., Cautela, J., & Galantini, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041780 · Cited by 186 · see citing works
Bile acids and their receptors
Martinot, E., Sèdes, L., Baptissart, M., Lobaccaro, J.-M., Caira, F., Beaudoin, C., & Volle, D. H. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.01.006 · Cited by 162 · see citing works
Nuclear receptors in bile acid metabolism
Li, T., & Chiang, J. Y. L. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.740048 · Cited by 176 · see citing works
Xu, Y., Li, F., Zalzala, M., Xu, J., Gonzalez, F. J., Adorini, L., Lee, Y., Yin, L., & Zhang, Y. (2016) · Hepatology · doi:10.1002/hep.28712 · Cited by 172 · see citing works
A nontumorigenic variant of FGF19 treats cholestatic liver diseases
Luo, J., Ko, B., Elliott, M., Zhou, M. L., Lindhout, D. A., Phung, V., To, C., Learned, R. M., Tian, H., DePaoli, A. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009098 · Cited by 167 · see citing works
Zhou, X., Cao, L., Jiang, C., Xie, Y., Cheng, X., Krausz, K. W., Qi, Y., Sun, L., Shah, Y. M., Gonzalez, F. J., et al. (2014) · Nature Communications · doi:10.1038/ncomms5573 · Cited by 163 · see citing works
Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice
Zhang, Y., Limaye, P. B., Renaud, H. J., & Klaassen, C. D. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.03.009 · Cited by 155 · see citing works
Bile acids and the metabolic syndrome
McGlone, E. R., & Bloom, S. R. (2018) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563218817798 · Cited by 154 · see citing works
Chen, J., Thomsen, M., & Vitetta, L. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27635 · Cited by 152 · see citing works
The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Chow, M. D., Lee, Y., & Guo, G. L. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.004 · Cited by 141 · see citing works
The influence of biological sex and sex hormones on bile acid synthesis and cholesterol homeostasis
Phelps, T., Snyder, E., Rodriguez, E., Child, H., & Harvey, P. A. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0265-3 · Cited by 141 · see citing works
Fibroblast Growth Factor Signaling in Metabolic Regulation
Nies, V. J. M., Sancar, G., Liu, W., van Zutphen, T., Struik, D., Yu, R. T., Atkins, A. R., Evans, R. M., Jonker, J. W., & Downes, M. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00193 · Cited by 135 · see citing works
Metabolic Messengers: fibroblast growth factor 15/19
Gadaleta, R. M., & Moschetta, A. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0074-3 · Cited by 137 · see citing works
How bile acids and the microbiota interact to shape host immunity
Lee, M. H., Nuccio, S.-P., Mohanty, I., Hagey, L. R., Dorrestein, P. C., Chu, H., & Raffatellu, M. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-024-01057-x · Cited by 143 · see citing works
Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR
Hiebl, V., Ladurner, A., Latkolik, S. L., & Dirsch, V. M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.003 · Cited by 135 · see citing works
Wu, Q., Sun, L., Hu, X., Wang, X., Xu, F., Chen, B., Liang, X., Xia, J., Wang, P., Aibara, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142865 · Cited by 131 · see citing works
Rodrigues, R. R., Greer, R. L., Dong, X., DSouza, K. N., Gurung, M., Wu, J. Y., Morgun, A., & Shulzhenko, N. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02306 · Cited by 127 · see citing works
Progress and challenges of selective Farnesoid X Receptor modulation
Massafra, V., Pellicciari, R., Gioiello, A., & van Mil, S. W. C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.009 · Cited by 129 · see citing works
The Gut–Liver Axis in the Control of Energy Metabolism and Food Intake in Animals
Ringseis, R., Geßner, D. K., & Eder, K. (2019) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-021419-083852 · Cited by 127 · see citing works
Hepatic transcriptional responses to fasting and feeding
Bideyan, L., Nagari, R., & Tontonoz, P. (2021) · Genes & Development · doi:10.1101/gad.348340.121 · Cited by 126 · see citing works
Degirolamo, C., Modica, S., Vacca, M., Di Tullio, G., Morgano, A., D'Orazio, A., Kannisto, K., Parini, P., & Moschetta, A. (2015) · Hepatology · doi:10.1002/hep.27274 · Cited by 121 · see citing works
Bile acids and their receptors in regulation of gut health and diseases
Lin, S., Wang, S., Wang, P., Tang, C., Wang, Z., Chen, L., Luo, G., Chen, H., Liu, Y., Feng, B., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101210 · Cited by 123 · see citing works
Ferrell, J. M., Boehme, S., Li, F., & Chiang, J. Y. L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m064709 · Cited by 112 · see citing works
Fatty liver diseases, bile acids, and FXR
Zhu, Y., Liu, H., Zhang, M., & Guo, G. L. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.07.008 · Cited by 118 · see citing works
Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives
Somm, E., & Jornayvaz, F. R. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00134 · Cited by 118 · see citing works
Zhang, Y., Xu, N., Xu, J. C., Kong, B., Copple, B. L., Guo, G. L., & Wang, L. (2014) · Hepatology · doi:10.1002/hep.27121 · Cited by 116 · see citing works
Bile acid metabolism and circadian rhythms
Yang, Y., & Zhang, J. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00152.2020 · Cited by 114 · see citing works
Farnesoid X receptor: A “homeostat” for hepatic nutrient metabolism
Massafra, V., & van Mil, S. W. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.003 · Cited by 113 · see citing works
Intestinal flora imbalance affects bile acid metabolism and is associated with gallstone formation
Wang, Q., Hao, C., Yao, W., Zhu, D., Lu, H., Li, L., Ma, B., Sun, B., Xue, D., & Zhang, W. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01195-1 · Cited by 113 · see citing works
Nuclear bile acid signaling through the farnesoid X receptor
Mazuy, C., Helleboid, A., Staels, B., & Lefebvre, P. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1805-y · Cited by 111 · see citing works
Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis
Simbrunner, B., Trauner, M. A., & Reiberger, T. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16602 · Cited by 107 · see citing works
Fibroblast growth factor 15 deficiency impairs liver regeneration in mice.
Kong, B., Huang, J., Zhu, Y., Li, G., Williams, J. A., Shen, S., Aleksunes, L., Richardson, J., Apte, U., Rudnick, D. A., et al. (2014) · American Journal of Physiology - Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00337.2013 · Cited by 107 · see citing works
Long Non-Coding RNAs: A Novel Paradigm for Toxicology
Dempsey, J. L., & Cui, J. Y. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw203 · Cited by 102 · see citing works
MAFG Is a Transcriptional Repressor of Bile Acid Synthesis and Metabolism
Vallim, T. Q. D. A., Tarling, E. J., Ahn, H., Hagey, L. R., Romanoski, C. E., Lee, R. G., Graham, M. J., Motohashi, H., Yamamoto, M. P., & Edwards, P. A. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.007 · Cited by 104 · see citing works
An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis
Wang, Y., Gunewardena, S., Li, F., Matye, D. J., Chen, C., Chao, X., Jung, T., Zhang, Y., Czerwiński, M., Ni, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17363-6 · Cited by 99 · see citing works
Wunsch, E., Milkiewicz, M., Wasik, U., Trottier, J., Kempińska‐Podhorodecka, A., Elias, E., Barbier, O., & Milkiewicz, P. (2015) · Scientific Reports · doi:10.1038/srep13462 · Cited by 97 · see citing works
Versatile Triad Alliance: Bile Acid, Taurine and Microbiota
Duszka, K. (2022) · Cells · doi:10.3390/cells11152337 · Cited by 100 · see citing works
Wen, J., Sun, H., Yang, B. V., Song, E., Song, Y., & Jiang, G. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.3c07108 · Cited by 97 · see citing works
Molecular features of bile salt hydrolases and relevance in human health
Chand, D., Avinash, V. S., Yadav, Y., Pundle, A. V., Suresh, C. G., & Ramasamy, S. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.024 · Cited by 95 · see citing works
Individual bile acids have differential effects on bile acid signaling in mice
Song, P., Rockwell, C. E., Cui, J. Y., & Klaassen, C. D. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.12.005 · Cited by 94 · see citing works
Liu, J., Lü, H., Lu, Y., Lei, X., Cui, J. Y., Ellis, E. C. S., Strom, S. C., & Klaassen, C. D. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu151 · Cited by 93 · see citing works
The Metabolic Role and Therapeutic Potential of the Microbiome
Olofsson, L. E., & Bäckhed, F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac004 · Cited by 95 · see citing works
Nuclear Receptor Control of Enterohepatic Circulation
Gonzalez, F. J. (2012) · Comprehensive physiology · doi:10.1002/cphy.c120007 · Cited by 91 · see citing works
Pereira-Fantini, P. M., Lapthorne, S., Joyce, S. A., Dellios, N. L., Wilson, G., Fouhy, F., Thomas, S., Scurr, M., Hill, C., Gahan, C. G. M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.025 · Cited by 90 · see citing works
Li, S., Hsu, D. D., Li, B., Luo, X., Alderson, N. B., Qiao, L., Ma, L., Zhu, H. H., He, Z., Suino-Powell, K. M., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.020 · Cited by 90 · see citing works
Liu, S., Marcelin, G., Blouet, C., Jeong, J. H., Jo, Y., Schwartz, G. J., & Chua, S. C. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.12.003 · Cited by 90 · see citing works
Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease
Li, T., & Chiang, J. Y. L. (2020) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2019.09.03 · Cited by 86 · see citing works
Recent advances on FXR-targeting therapeutics
Panzitt, K., Zollner, G., Marschall, H., & Wagner, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111678 · Cited by 86 · see citing works
ASBT(SLC10A2): A promising target for treatment of diseases and drug discovery
Yang, N., Dong, Y., Jia, G., Fan, S., Li, S.-Z., Yang, S., & Li, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110835 · Cited by 85 · see citing works
Stepanov, V., Stankov, K., & Mikov, M. (2013) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2013.802805 · Cited by 84 · see citing works
Matziouridou, C., Marungruang, N., Nguyen, T. D., NYMAN, M. E., & Fåk, F. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500738 · Cited by 84 · see citing works
Massafra, V., Milona, A., Vos, H. R., Ramos, R. J. J. F., Gerrits, J., Willemsen, E. C. L., Pittol, J. M. R., Ijssennagger, N., Houweling, M., Prinsen, H. C. M. T., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.014 · Cited by 82 · see citing works
Increased Bile Acid Synthesis and Deconjugation After Biliopancreatic Diversion
Ferrannini, E., Camastra, S., Astiarraga, B., Nannipieri, M., Castro‐Perez, J. M., Xie, D., Wang, L., Chakravarthy, M. V., & Haeusler, R. A. (2015) · Diabetes · doi:10.2337/db15-0214 · Cited by 80 · see citing works
Schumacher, J. D., Kong, B., Wu, B. J., Rizzolo, D., Armstrong, L. E., Chow, M. D., Goedken, M. J., Lee, Y., & Guo, G. L. (2019) · Hepatology · doi:10.1002/hep.30810 · Cited by 80 · see citing works
Nonsteroidal FXR Ligands: Current Status and Clinical Applications
Gege, C., Hambruch, E., Hambruch, N., Kinzel, O., & Kremoser, C. (2019) · Handbook of Experimental Pharmacology · doi:10.1007/164_2019_232 · Cited by 83 · see citing works
Elevated copper impairs hepatic nuclear receptor function in Wilson’s disease
Wooton‐Kee, C. R., Jain, A. K., Wagner, M., Grusak, M. A., Finegold, M. J., Lutsenko, S., & Moore, D. D. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78991 · Cited by 79 · see citing works
Kong, B., Zhang, M., Huang, M., Rizzolo, D., Armstrong, L. E., Schumacher, J. D., Chow, M. D., Lee, Y., & Guo, G. L. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.12.026 · Cited by 78 · see citing works
Bile acid-mediated signaling in cholestatic liver diseases
Zeng, J., Fan, J., & Zhou, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01035-1 · Cited by 78 · see citing works
Meng, Q., Chen, X.-L., Wang, C., Liu, Q., Sun, H., Sun, P., Huo, X., Liu, Z., Yao, J., & Liu, K. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.01.020 · Cited by 79 · see citing works
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 77 · see citing works
Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
Li, G., & Guo, G. L. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.01.005 · Cited by 77 · see citing works
Kazgan, N., Metukuri, M. R., Purushotham, A., Lü, J., Rao, A., Lee, S., Pratt–Hyatt, M., Lickteig, A. J., Csanaky, I. L., Zhao, Y., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.029 · Cited by 76 · see citing works
Byun, S., Kim, D.-H., Ryerson, D., Kim, Y., Sun, H., Kong, B., Yau, P. M., Guo, G. L., Xu, H. E., KEMPER, B. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04697-5 · Cited by 75 · see citing works
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Zhang, Y., Li, Z.-J., Gou, H.-Z., Song, X., & Zhang, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.945368 · Cited by 74 · see citing works
Kulkarni, S. R., Soroka, C. J., Hagey, L. R., & Boyer, J. L. (2016) · Hepatology · doi:10.1002/hep.28826 · Cited by 73 · see citing works
- Authors
- Kong, B., Wang, L., Chiang, J. Y. L., Zhang, Y., Klaassen, C. D., & Guo, G. L.
- Affiliations
- University of Kansas Medical Center (US)
- University of Utah (US)
- Northeast Ohio Medical University (US)
- Corresponding author
- Guo, Grace L.
- Venue
- Hepatology
- Published
- 2012-09
- Volume
- 56
- Issue
- 3
- Pages
- 1034-1043
- ISSN
- 0270-9139 (ISSN-L)
- PMC
- PMC3390456
- OpenAlex
- W2046811888
- Cited by
- 456
- References
- 33
- Citations by year
- 2026: 31 · 2025: 36 · 2024: 34 · 2023: 51 · 2022: 41 · 2021: 37 · 2020: 30 · 2019: 28 · 2018: 36 · 2017: 33 · 2016: 25 · 2015: 24 · 2014: 28 · 2013: 16 · 2012: 5
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01dk044442-26)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080440, DK-081343, R56DK090036, R01-DK-044442, R01DK081343, R01DK44442, R37DK058379)
- National Center for Research Resources (P20RR021940)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- farnesoid X receptor, bile acid synthesis, CYP7A1, CYP8B1, small heterodimer partner, FGF15, FGF19, ERK signaling, JNK signaling, tissue-specific gene regulation
- MeSH terms
- Receptor, Farnesoid X-Activated, Animals, Bile Acids and Salts, Gene Expression, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review